nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—migraine—Prednisone—systemic scleroderma	0.85	1	CpDpCtD
Metoclopramide—Sunitinib—BLK—systemic scleroderma	0.00264	1	CrCbGaD
Metoclopramide—HTR3A—myenteric nerve plexus—systemic scleroderma	0.00105	0.721	CbGeAlD
Metoclopramide—Flushing—Captopril—systemic scleroderma	0.00057	0.00391	CcSEcCtD
Metoclopramide—Neutropenia—Mycophenolic acid—systemic scleroderma	0.000564	0.00387	CcSEcCtD
Metoclopramide—Tachycardia—Pentoxifylline—systemic scleroderma	0.000562	0.00386	CcSEcCtD
Metoclopramide—Pollakiuria—Mycophenolic acid—systemic scleroderma	0.000557	0.00383	CcSEcCtD
Metoclopramide—Agranulocytosis—Azathioprine—systemic scleroderma	0.000557	0.00383	CcSEcCtD
Metoclopramide—Hepatotoxicity—Methotrexate—systemic scleroderma	0.000557	0.00382	CcSEcCtD
Metoclopramide—Angioedema—Mometasone—systemic scleroderma	0.000556	0.00382	CcSEcCtD
Metoclopramide—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.000556	0.00382	CcSEcCtD
Metoclopramide—Jaundice—Leflunomide—systemic scleroderma	0.00055	0.00377	CcSEcCtD
Metoclopramide—Asthma—Lisinopril—systemic scleroderma	0.000543	0.00373	CcSEcCtD
Metoclopramide—Hypotension—Pentoxifylline—systemic scleroderma	0.000538	0.00369	CcSEcCtD
Metoclopramide—Bronchospasm—Lisinopril—systemic scleroderma	0.000535	0.00367	CcSEcCtD
Metoclopramide—Agranulocytosis—Leflunomide—systemic scleroderma	0.000526	0.00361	CcSEcCtD
Metoclopramide—Jaundice—Mycophenolic acid—systemic scleroderma	0.000524	0.0036	CcSEcCtD
Metoclopramide—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.000524	0.0036	CcSEcCtD
Metoclopramide—Insomnia—Pentoxifylline—systemic scleroderma	0.000521	0.00358	CcSEcCtD
Metoclopramide—Nervousness—Captopril—systemic scleroderma	0.000519	0.00357	CcSEcCtD
Metoclopramide—Dyspnoea—Pentoxifylline—systemic scleroderma	0.000513	0.00353	CcSEcCtD
Metoclopramide—Somnolence—Pentoxifylline—systemic scleroderma	0.000512	0.00352	CcSEcCtD
Metoclopramide—Neutropenia—Lisinopril—systemic scleroderma	0.000508	0.00349	CcSEcCtD
Metoclopramide—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.000502	0.00345	CcSEcCtD
Metoclopramide—Erectile dysfunction—Lisinopril—systemic scleroderma	0.000501	0.00344	CcSEcCtD
Metoclopramide—Bradycardia—Mycophenolic acid—systemic scleroderma	0.000492	0.00338	CcSEcCtD
Metoclopramide—Angioedema—Captopril—systemic scleroderma	0.000489	0.00335	CcSEcCtD
Metoclopramide—Fluid retention—Prednisone—systemic scleroderma	0.000488	0.00335	CcSEcCtD
Metoclopramide—Depression—Lisinopril—systemic scleroderma	0.000483	0.00332	CcSEcCtD
Metoclopramide—Hallucination—Mycophenolic acid—systemic scleroderma	0.000481	0.0033	CcSEcCtD
Metoclopramide—Asthma—Mycophenolate mofetil—systemic scleroderma	0.000476	0.00327	CcSEcCtD
Metoclopramide—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000474	0.00326	CcSEcCtD
Metoclopramide—Palpitations—Captopril—systemic scleroderma	0.000473	0.00324	CcSEcCtD
Metoclopramide—Jaundice—Lisinopril—systemic scleroderma	0.000472	0.00324	CcSEcCtD
Metoclopramide—Visual impairment—Mycophenolic acid—systemic scleroderma	0.000465	0.0032	CcSEcCtD
Metoclopramide—Urticaria—Pentoxifylline—systemic scleroderma	0.000457	0.00314	CcSEcCtD
Metoclopramide—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000455	0.00313	CcSEcCtD
Metoclopramide—Agranulocytosis—Lisinopril—systemic scleroderma	0.000452	0.00311	CcSEcCtD
Metoclopramide—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.000445	0.00306	CcSEcCtD
Metoclopramide—Dyspnoea—Mometasone—systemic scleroderma	0.000443	0.00304	CcSEcCtD
Metoclopramide—Bradycardia—Lisinopril—systemic scleroderma	0.000443	0.00304	CcSEcCtD
Metoclopramide—Confusional state—Captopril—systemic scleroderma	0.00044	0.00302	CcSEcCtD
Metoclopramide—Pollakiuria—Mycophenolate mofetil—systemic scleroderma	0.00044	0.00302	CcSEcCtD
Metoclopramide—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.000439	0.00301	CcSEcCtD
Metoclopramide—Respiratory failure—Methotrexate—systemic scleroderma	0.000438	0.00301	CcSEcCtD
Metoclopramide—Hallucination—Lisinopril—systemic scleroderma	0.000433	0.00297	CcSEcCtD
Metoclopramide—Fatigue—Mometasone—systemic scleroderma	0.000428	0.00294	CcSEcCtD
Metoclopramide—Tachycardia—Captopril—systemic scleroderma	0.000426	0.00292	CcSEcCtD
Metoclopramide—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000424	0.00291	CcSEcCtD
Metoclopramide—Muscle spasms—Leflunomide—systemic scleroderma	0.000424	0.00291	CcSEcCtD
Metoclopramide—Depression—Mycophenolate mofetil—systemic scleroderma	0.000423	0.00291	CcSEcCtD
Metoclopramide—Leukopenia—Azathioprine—systemic scleroderma	0.000418	0.00287	CcSEcCtD
Metoclopramide—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00284	CcSEcCtD
Metoclopramide—Asthenia—Pentoxifylline—systemic scleroderma	0.000413	0.00284	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Prednisone—systemic scleroderma	0.000412	0.00283	CcSEcCtD
Metoclopramide—Nervousness—Mycophenolic acid—systemic scleroderma	0.000408	0.0028	CcSEcCtD
Metoclopramide—Hypotension—Captopril—systemic scleroderma	0.000408	0.0028	CcSEcCtD
Metoclopramide—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000404	0.00278	CcSEcCtD
Metoclopramide—Flushing—Lisinopril—systemic scleroderma	0.000404	0.00277	CcSEcCtD
Metoclopramide—Angioedema—Leflunomide—systemic scleroderma	0.000403	0.00277	CcSEcCtD
Metoclopramide—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000396	0.00272	CcSEcCtD
Metoclopramide—Insomnia—Captopril—systemic scleroderma	0.000395	0.00271	CcSEcCtD
Metoclopramide—Leukopenia—Leflunomide—systemic scleroderma	0.000394	0.00271	CcSEcCtD
Metoclopramide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000394	0.00271	CcSEcCtD
Metoclopramide—Tremor—Mycophenolic acid—systemic scleroderma	0.000394	0.0027	CcSEcCtD
Metoclopramide—Body temperature increased—Mometasone—systemic scleroderma	0.000393	0.0027	CcSEcCtD
Metoclopramide—Palpitations—Leflunomide—systemic scleroderma	0.000389	0.00267	CcSEcCtD
Metoclopramide—Dyspnoea—Captopril—systemic scleroderma	0.000389	0.00267	CcSEcCtD
Metoclopramide—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000388	0.00266	CcSEcCtD
Metoclopramide—Somnolence—Captopril—systemic scleroderma	0.000388	0.00266	CcSEcCtD
Metoclopramide—Agitation—Mycophenolic acid—systemic scleroderma	0.000386	0.00265	CcSEcCtD
Metoclopramide—Gynaecomastia—Methotrexate—systemic scleroderma	0.000385	0.00264	CcSEcCtD
Metoclopramide—Dizziness—Pentoxifylline—systemic scleroderma	0.000381	0.00261	CcSEcCtD
Metoclopramide—Hypertension—Leflunomide—systemic scleroderma	0.00038	0.00261	CcSEcCtD
Metoclopramide—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000379	0.0026	CcSEcCtD
Metoclopramide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000376	0.00258	CcSEcCtD
Metoclopramide—Fatigue—Captopril—systemic scleroderma	0.000376	0.00258	CcSEcCtD
Metoclopramide—Anxiety—Leflunomide—systemic scleroderma	0.000374	0.00257	CcSEcCtD
Metoclopramide—Palpitations—Mycophenolic acid—systemic scleroderma	0.000372	0.00255	CcSEcCtD
Metoclopramide—Nervousness—Lisinopril—systemic scleroderma	0.000368	0.00253	CcSEcCtD
Metoclopramide—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000367	0.00252	CcSEcCtD
Metoclopramide—Convulsion—Mycophenolic acid—systemic scleroderma	0.000364	0.0025	CcSEcCtD
Metoclopramide—Muscle spasms—Lisinopril—systemic scleroderma	0.000364	0.0025	CcSEcCtD
Metoclopramide—Rash—Pentoxifylline—systemic scleroderma	0.000363	0.00249	CcSEcCtD
Metoclopramide—Hypertension—Mycophenolic acid—systemic scleroderma	0.000363	0.00249	CcSEcCtD
Metoclopramide—Dermatitis—Pentoxifylline—systemic scleroderma	0.000363	0.00249	CcSEcCtD
Metoclopramide—Headache—Pentoxifylline—systemic scleroderma	0.000361	0.00248	CcSEcCtD
Metoclopramide—Feeling abnormal—Captopril—systemic scleroderma	0.00036	0.00247	CcSEcCtD
Metoclopramide—Anxiety—Mycophenolic acid—systemic scleroderma	0.000357	0.00245	CcSEcCtD
Metoclopramide—Asthenia—Mometasone—systemic scleroderma	0.000356	0.00245	CcSEcCtD
Metoclopramide—Hypotension—Azathioprine—systemic scleroderma	0.000356	0.00244	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisone—systemic scleroderma	0.000355	0.00244	CcSEcCtD
Metoclopramide—Tremor—Lisinopril—systemic scleroderma	0.000355	0.00244	CcSEcCtD
Metoclopramide—Tachycardia—Leflunomide—systemic scleroderma	0.000351	0.00241	CcSEcCtD
Metoclopramide—Angioedema—Lisinopril—systemic scleroderma	0.000346	0.00238	CcSEcCtD
Metoclopramide—Confusional state—Mycophenolic acid—systemic scleroderma	0.000346	0.00238	CcSEcCtD
Metoclopramide—Body temperature increased—Captopril—systemic scleroderma	0.000345	0.00237	CcSEcCtD
Metoclopramide—Oedema—Mycophenolic acid—systemic scleroderma	0.000343	0.00236	CcSEcCtD
Metoclopramide—Nausea—Pentoxifylline—systemic scleroderma	0.000342	0.00235	CcSEcCtD
Metoclopramide—Diarrhoea—Mometasone—systemic scleroderma	0.00034	0.00233	CcSEcCtD
Metoclopramide—Leukopenia—Lisinopril—systemic scleroderma	0.000339	0.00233	CcSEcCtD
Metoclopramide—Hypotension—Leflunomide—systemic scleroderma	0.000336	0.00231	CcSEcCtD
Metoclopramide—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000335	0.0023	CcSEcCtD
Metoclopramide—Palpitations—Lisinopril—systemic scleroderma	0.000335	0.0023	CcSEcCtD
Metoclopramide—Visual disturbance—Methotrexate—systemic scleroderma	0.000329	0.00226	CcSEcCtD
Metoclopramide—Insomnia—Leflunomide—systemic scleroderma	0.000325	0.00223	CcSEcCtD
Metoclopramide—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000322	0.00221	CcSEcCtD
Metoclopramide—Anxiety—Lisinopril—systemic scleroderma	0.000321	0.00221	CcSEcCtD
Metoclopramide—Dyspnoea—Leflunomide—systemic scleroderma	0.000321	0.0022	CcSEcCtD
Metoclopramide—Hypotension—Mycophenolic acid—systemic scleroderma	0.000321	0.0022	CcSEcCtD
Metoclopramide—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000319	0.00219	CcSEcCtD
Metoclopramide—Feeling abnormal—Azathioprine—systemic scleroderma	0.000314	0.00216	CcSEcCtD
Metoclopramide—Rash—Mometasone—systemic scleroderma	0.000313	0.00215	CcSEcCtD
Metoclopramide—Asthenia—Captopril—systemic scleroderma	0.000313	0.00215	CcSEcCtD
Metoclopramide—Dermatitis—Mometasone—systemic scleroderma	0.000313	0.00215	CcSEcCtD
Metoclopramide—Confusional state—Lisinopril—systemic scleroderma	0.000312	0.00214	CcSEcCtD
Metoclopramide—Headache—Mometasone—systemic scleroderma	0.000311	0.00214	CcSEcCtD
Metoclopramide—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000311	0.00213	CcSEcCtD
Metoclopramide—Insomnia—Mycophenolic acid—systemic scleroderma	0.00031	0.00213	CcSEcCtD
Metoclopramide—Fatigue—Leflunomide—systemic scleroderma	0.00031	0.00213	CcSEcCtD
Metoclopramide—Oedema—Lisinopril—systemic scleroderma	0.000309	0.00212	CcSEcCtD
Metoclopramide—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000306	0.0021	CcSEcCtD
Metoclopramide—Somnolence—Mycophenolic acid—systemic scleroderma	0.000305	0.00209	CcSEcCtD
Metoclopramide—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000305	0.00209	CcSEcCtD
Metoclopramide—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000303	0.00208	CcSEcCtD
Metoclopramide—Neutropenia—Prednisone—systemic scleroderma	0.000302	0.00207	CcSEcCtD
Metoclopramide—Tachycardia—Lisinopril—systemic scleroderma	0.000302	0.00207	CcSEcCtD
Metoclopramide—Body temperature increased—Azathioprine—systemic scleroderma	0.000301	0.00207	CcSEcCtD
Metoclopramide—Diarrhoea—Captopril—systemic scleroderma	0.000299	0.00205	CcSEcCtD
Metoclopramide—Erectile dysfunction—Prednisone—systemic scleroderma	0.000297	0.00204	CcSEcCtD
Metoclopramide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000297	0.00204	CcSEcCtD
Metoclopramide—Feeling abnormal—Leflunomide—systemic scleroderma	0.000296	0.00204	CcSEcCtD
Metoclopramide—Fatigue—Mycophenolic acid—systemic scleroderma	0.000296	0.00203	CcSEcCtD
Metoclopramide—Nausea—Mometasone—systemic scleroderma	0.000295	0.00203	CcSEcCtD
Metoclopramide—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000293	0.00201	CcSEcCtD
Metoclopramide—Hypotension—Lisinopril—systemic scleroderma	0.000289	0.00198	CcSEcCtD
Metoclopramide—Dizziness—Captopril—systemic scleroderma	0.000289	0.00198	CcSEcCtD
Metoclopramide—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00197	CcSEcCtD
Metoclopramide—Depression—Prednisone—systemic scleroderma	0.000287	0.00197	CcSEcCtD
Metoclopramide—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000286	0.00197	CcSEcCtD
Metoclopramide—Urticaria—Leflunomide—systemic scleroderma	0.000286	0.00196	CcSEcCtD
Metoclopramide—Body temperature increased—Leflunomide—systemic scleroderma	0.000284	0.00195	CcSEcCtD
Metoclopramide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000283	0.00194	CcSEcCtD
Metoclopramide—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000281	0.00193	CcSEcCtD
Metoclopramide—Hypersensitivity—Azathioprine—systemic scleroderma	0.000281	0.00193	CcSEcCtD
Metoclopramide—Insomnia—Lisinopril—systemic scleroderma	0.00028	0.00192	CcSEcCtD
Metoclopramide—Dyspnoea—Lisinopril—systemic scleroderma	0.000276	0.00189	CcSEcCtD
Metoclopramide—Rash—Captopril—systemic scleroderma	0.000275	0.00189	CcSEcCtD
Metoclopramide—Dermatitis—Captopril—systemic scleroderma	0.000275	0.00189	CcSEcCtD
Metoclopramide—Somnolence—Lisinopril—systemic scleroderma	0.000275	0.00189	CcSEcCtD
Metoclopramide—Headache—Captopril—systemic scleroderma	0.000273	0.00188	CcSEcCtD
Metoclopramide—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000273	0.00187	CcSEcCtD
Metoclopramide—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000271	0.00186	CcSEcCtD
Metoclopramide—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000271	0.00186	CcSEcCtD
Metoclopramide—Asthma—Methotrexate—systemic scleroderma	0.00027	0.00185	CcSEcCtD
Metoclopramide—Fatigue—Lisinopril—systemic scleroderma	0.000266	0.00183	CcSEcCtD
Metoclopramide—Hypersensitivity—Leflunomide—systemic scleroderma	0.000265	0.00182	CcSEcCtD
Metoclopramide—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000264	0.00181	CcSEcCtD
Metoclopramide—Bradycardia—Prednisone—systemic scleroderma	0.000263	0.00181	CcSEcCtD
Metoclopramide—Diarrhoea—Azathioprine—systemic scleroderma	0.000261	0.00179	CcSEcCtD
Metoclopramide—Nausea—Captopril—systemic scleroderma	0.000259	0.00178	CcSEcCtD
Metoclopramide—Asthenia—Leflunomide—systemic scleroderma	0.000258	0.00177	CcSEcCtD
Metoclopramide—Hallucination—Prednisone—systemic scleroderma	0.000257	0.00177	CcSEcCtD
Metoclopramide—Feeling abnormal—Lisinopril—systemic scleroderma	0.000255	0.00175	CcSEcCtD
Metoclopramide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00174	CcSEcCtD
Metoclopramide—Neutropenia—Methotrexate—systemic scleroderma	0.000252	0.00173	CcSEcCtD
Metoclopramide—Dizziness—Azathioprine—systemic scleroderma	0.000252	0.00173	CcSEcCtD
Metoclopramide—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000248	0.00171	CcSEcCtD
Metoclopramide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000246	0.00169	CcSEcCtD
Metoclopramide—Diarrhoea—Leflunomide—systemic scleroderma	0.000246	0.00169	CcSEcCtD
Metoclopramide—Urticaria—Lisinopril—systemic scleroderma	0.000246	0.00169	CcSEcCtD
Metoclopramide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00168	CcSEcCtD
Metoclopramide—Body temperature increased—Lisinopril—systemic scleroderma	0.000244	0.00168	CcSEcCtD
Metoclopramide—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00166	CcSEcCtD
Metoclopramide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00165	CcSEcCtD
Metoclopramide—Drowsiness—Methotrexate—systemic scleroderma	0.000241	0.00165	CcSEcCtD
Metoclopramide—Rash—Azathioprine—systemic scleroderma	0.00024	0.00165	CcSEcCtD
Metoclopramide—Dermatitis—Azathioprine—systemic scleroderma	0.00024	0.00165	CcSEcCtD
Metoclopramide—Depression—Methotrexate—systemic scleroderma	0.00024	0.00165	CcSEcCtD
Metoclopramide—Flushing—Prednisone—systemic scleroderma	0.00024	0.00165	CcSEcCtD
Metoclopramide—Headache—Azathioprine—systemic scleroderma	0.000239	0.00164	CcSEcCtD
Metoclopramide—Dizziness—Leflunomide—systemic scleroderma	0.000238	0.00163	CcSEcCtD
Metoclopramide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000235	0.00161	CcSEcCtD
Metoclopramide—Hypersensitivity—Lisinopril—systemic scleroderma	0.000228	0.00156	CcSEcCtD
Metoclopramide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000227	0.00156	CcSEcCtD
Metoclopramide—Rash—Leflunomide—systemic scleroderma	0.000227	0.00156	CcSEcCtD
Metoclopramide—Dermatitis—Leflunomide—systemic scleroderma	0.000227	0.00156	CcSEcCtD
Metoclopramide—Nausea—Azathioprine—systemic scleroderma	0.000226	0.00155	CcSEcCtD
Metoclopramide—Headache—Leflunomide—systemic scleroderma	0.000225	0.00155	CcSEcCtD
Metoclopramide—Agranulocytosis—Methotrexate—systemic scleroderma	0.000224	0.00154	CcSEcCtD
Metoclopramide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000223	0.00153	CcSEcCtD
Metoclopramide—Asthenia—Lisinopril—systemic scleroderma	0.000222	0.00152	CcSEcCtD
Metoclopramide—Rash—Mycophenolic acid—systemic scleroderma	0.000216	0.00149	CcSEcCtD
Metoclopramide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000216	0.00148	CcSEcCtD
Metoclopramide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000215	0.00148	CcSEcCtD
Metoclopramide—Headache—Mycophenolic acid—systemic scleroderma	0.000215	0.00148	CcSEcCtD
Metoclopramide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000214	0.00147	CcSEcCtD
Metoclopramide—Nausea—Leflunomide—systemic scleroderma	0.000214	0.00147	CcSEcCtD
Metoclopramide—Diarrhoea—Lisinopril—systemic scleroderma	0.000211	0.00145	CcSEcCtD
Metoclopramide—Visual impairment—Methotrexate—systemic scleroderma	0.000208	0.00143	CcSEcCtD
Metoclopramide—Agitation—Prednisone—systemic scleroderma	0.000207	0.00142	CcSEcCtD
Metoclopramide—Angioedema—Prednisone—systemic scleroderma	0.000205	0.00141	CcSEcCtD
Metoclopramide—Dizziness—Lisinopril—systemic scleroderma	0.000204	0.0014	CcSEcCtD
Metoclopramide—Nausea—Mycophenolic acid—systemic scleroderma	0.000204	0.0014	CcSEcCtD
Metoclopramide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000199	0.00137	CcSEcCtD
Metoclopramide—Rash—Lisinopril—systemic scleroderma	0.000195	0.00134	CcSEcCtD
Metoclopramide—Convulsion—Prednisone—systemic scleroderma	0.000195	0.00134	CcSEcCtD
Metoclopramide—Dermatitis—Lisinopril—systemic scleroderma	0.000195	0.00134	CcSEcCtD
Metoclopramide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000194	0.00133	CcSEcCtD
Metoclopramide—Hypertension—Prednisone—systemic scleroderma	0.000194	0.00133	CcSEcCtD
Metoclopramide—Headache—Lisinopril—systemic scleroderma	0.000194	0.00133	CcSEcCtD
Metoclopramide—Anxiety—Prednisone—systemic scleroderma	0.000191	0.00131	CcSEcCtD
Metoclopramide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000185	0.00127	CcSEcCtD
Metoclopramide—Nausea—Lisinopril—systemic scleroderma	0.000184	0.00126	CcSEcCtD
Metoclopramide—Oedema—Prednisone—systemic scleroderma	0.000184	0.00126	CcSEcCtD
Metoclopramide—Tachycardia—Prednisone—systemic scleroderma	0.000179	0.00123	CcSEcCtD
Metoclopramide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000179	0.00123	CcSEcCtD
Metoclopramide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000171	0.00117	CcSEcCtD
Metoclopramide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000171	0.00117	CcSEcCtD
Metoclopramide—Headache—Mycophenolate mofetil—systemic scleroderma	0.00017	0.00116	CcSEcCtD
Metoclopramide—Leukopenia—Methotrexate—systemic scleroderma	0.000168	0.00116	CcSEcCtD
Metoclopramide—Insomnia—Prednisone—systemic scleroderma	0.000166	0.00114	CcSEcCtD
Metoclopramide—Convulsion—Methotrexate—systemic scleroderma	0.000163	0.00112	CcSEcCtD
Metoclopramide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000161	0.0011	CcSEcCtD
Metoclopramide—Fatigue—Prednisone—systemic scleroderma	0.000158	0.00109	CcSEcCtD
Metoclopramide—Confusional state—Methotrexate—systemic scleroderma	0.000155	0.00106	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisone—systemic scleroderma	0.000151	0.00104	CcSEcCtD
Metoclopramide—Urticaria—Prednisone—systemic scleroderma	0.000146	0.001	CcSEcCtD
Metoclopramide—Body temperature increased—Prednisone—systemic scleroderma	0.000145	0.000996	CcSEcCtD
Metoclopramide—Hypotension—Methotrexate—systemic scleroderma	0.000143	0.000984	CcSEcCtD
Metoclopramide—CYP17A1—connective tissue—systemic scleroderma	0.000141	0.0963	CbGeAlD
Metoclopramide—Insomnia—Methotrexate—systemic scleroderma	0.000139	0.000953	CcSEcCtD
Metoclopramide—Dyspnoea—Methotrexate—systemic scleroderma	0.000137	0.000939	CcSEcCtD
Metoclopramide—Somnolence—Methotrexate—systemic scleroderma	0.000136	0.000936	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisone—systemic scleroderma	0.000135	0.000929	CcSEcCtD
Metoclopramide—Fatigue—Methotrexate—systemic scleroderma	0.000132	0.000908	CcSEcCtD
Metoclopramide—Asthenia—Prednisone—systemic scleroderma	0.000132	0.000904	CcSEcCtD
Metoclopramide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000126	0.000868	CcSEcCtD
Metoclopramide—Diarrhoea—Prednisone—systemic scleroderma	0.000126	0.000862	CcSEcCtD
Metoclopramide—Urticaria—Methotrexate—systemic scleroderma	0.000122	0.000837	CcSEcCtD
Metoclopramide—Dizziness—Prednisone—systemic scleroderma	0.000121	0.000833	CcSEcCtD
Metoclopramide—Body temperature increased—Methotrexate—systemic scleroderma	0.000121	0.000833	CcSEcCtD
Metoclopramide—Rash—Prednisone—systemic scleroderma	0.000116	0.000795	CcSEcCtD
Metoclopramide—Dermatitis—Prednisone—systemic scleroderma	0.000116	0.000794	CcSEcCtD
Metoclopramide—Headache—Prednisone—systemic scleroderma	0.000115	0.00079	CcSEcCtD
Metoclopramide—Hypersensitivity—Methotrexate—systemic scleroderma	0.000113	0.000776	CcSEcCtD
Metoclopramide—Asthenia—Methotrexate—systemic scleroderma	0.00011	0.000756	CcSEcCtD
Metoclopramide—Nausea—Prednisone—systemic scleroderma	0.000109	0.000749	CcSEcCtD
Metoclopramide—Diarrhoea—Methotrexate—systemic scleroderma	0.000105	0.000721	CcSEcCtD
Metoclopramide—Dizziness—Methotrexate—systemic scleroderma	0.000101	0.000697	CcSEcCtD
Metoclopramide—Rash—Methotrexate—systemic scleroderma	9.67e-05	0.000664	CcSEcCtD
Metoclopramide—Dermatitis—Methotrexate—systemic scleroderma	9.66e-05	0.000664	CcSEcCtD
Metoclopramide—Headache—Methotrexate—systemic scleroderma	9.61e-05	0.00066	CcSEcCtD
Metoclopramide—Nausea—Methotrexate—systemic scleroderma	9.11e-05	0.000626	CcSEcCtD
Metoclopramide—HTR3A—digestive system—systemic scleroderma	7.97e-05	0.0546	CbGeAlD
Metoclopramide—HTR3A—lung—systemic scleroderma	6.66e-05	0.0456	CbGeAlD
Metoclopramide—CHRM1—lung—systemic scleroderma	5.06e-05	0.0346	CbGeAlD
Metoclopramide—DRD2—lung—systemic scleroderma	4.07e-05	0.0279	CbGeAlD
Metoclopramide—CYP2D6—digestive system—systemic scleroderma	2.93e-05	0.0201	CbGeAlD
